HEALY JAMES
CIK 1245624
Transactions on file
12
Open-market buys
4
Win rate (buys)
100%
4 scored
Avg % since filing (buys)
+10.3%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-11-01 | 2026-10-28 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 6,933 | $145.6K | +10.3% | open → |
| 2026-11-01 | 2026-10-28 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 3,772 | $79.2K | +10.3% | open → |
| 2026-11-01 | 2026-10-28 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 6,395 | $134.3K | +10.3% | open → |
| 2026-11-01 | 2026-10-28 | RAPP Rapport Therapeutics, Inc. | Director | Buy | 952,380 | $20.00M | +10.3% | open → |
| 2025-02-04 | 2025-01-31 | NTRA Natera, Inc. | Director | Grant | 114 | — | — | open → |
| 2025-04-29 | 2025-04-25 | NTRA Natera, Inc. | Director | Grant | 142 | — | — | open → |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 804,379 | $0.00 | — | open → | |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 1,927,159 | $0.00 | — | open → | |
| 2025-07-02 | 2025-06-30 | YMAB Y-mAbs Therapeutics, Inc. | Director | Grant | 25,080 | $0.00 | — | open → |
| 2025-09-18 | 2025-09-16 | YMAB Y-mAbs Therapeutics, Inc. | Director | Disp. | 25,080 | — | — | open → |
| 2025-09-18 | 2025-09-16 | YMAB Y-mAbs Therapeutics, Inc. | Director | U | 2,194,278 | $18.87M | — | open → |
| 2025-09-18 | 2025-09-16 | YMAB Y-mAbs Therapeutics, Inc. | Director | U | 31,603 | $271.8K | — | open → |